SCHEMBL8685355

SCHEMBL8685355

O=Cc1cccc2c1ccn2C(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
TSHR P16473 1/20 0.55
RAB9A P51151 1/20 0.55
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
THRB P10828 1/20 0.46
KMT2A Q03164 1/20 0.46
PTGS2 P35354 4/20 0.45
P2RX4 Q99571 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31668328 1.00 L3MBTL1 (0.55) L3MBTL1TSHRRAB9APDCD1CD274
SCHEMBL14519052 0.81 PTGS2 (0.64) L3MBTL1ALDH1A1KDM4ETHRBKMT2A
SCHEMBL9854713 0.80 NOTUM (0.61) RAB9AALDH1A1KMT2APOLBNOTUM
SCHEMBL8686727 0.78 APP (0.40) PDCD1CD274ALDH1A1KMT2AHDAC8
SCHEMBL28721669 0.78 L3MBTL1 (0.58) L3MBTL1TSHRRAB9APDCD1CD274
SCHEMBL1247821 0.78 TSHR (0.54) L3MBTL1TSHRRAB9APDCD1CD274
SCHEMBL20905239 0.77 NOTUM (0.40) ALDH1A1ACHENOTUMIMPDH2
SCHEMBL10267835 0.76 TSHR (0.55) L3MBTL1TSHRRAB9APDCD1CD274
SCHEMBL28720956 0.76 L3MBTL1 (0.55) L3MBTL1TSHRRAB9APDCD1CD274
SCHEMBL8685214 0.75 KMT2A (0.51) RAB9AALDH1A1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed